Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psychedelic treatments for mental health conditions pose challenges for informed consent
Carolina Seybert, Gonçalo Cotovio, Luís Madeira, et al.
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2167-2170
Closed Access | Times Cited: 16

Showing 16 citing articles:

Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research
Roger S McIntyre, Angela T.H. Kwan, Rodrigo B. Mansur, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 21-32
Closed Access | Times Cited: 3
Therapeutic mechanisms of psychedelics and entactogens
Boris D. Heifets, David E. Olson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 104-118
Closed Access | Times Cited: 30
Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research
Kelley C. O’Donnell, Jim Grigsby, Charles S. Grob
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 13-16
Closed Access | Times Cited: 1
Practical considerations in the establishment of psychedelic research programs
Brian S. Barnett, M. Frances Vest, Marcus S. Delatte, et al.
Psychopharmacology (2024)
Open Access | Times Cited: 4
Serotonin 5-HT 2B receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents
Roger S. McIntyre
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 10, pp. 881-883
Open Access | Times Cited: 10
Informed Consent to Psychedelic Medicine
Burton J. Tabaac, Mitchell D. Feldman, Owen S. Muir
American Journal of Therapeutics (2025) Vol. 32, Iss. 1, pp. e37-e39
Closed Access
Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper
Marianne Destoop, Pavel Mohr, Florence Butlen-Ducuing, et al.
European Psychiatry (2025) Vol. 68, Iss. 1
Open Access
A review of psychedelics trials completed in depression, informed by European regulatory perspectives
Francisca Silva, Florence Butlen-Ducuing, Lorenzo Guizzaro, et al.
Neuroscience Applied (2025), pp. 105516-105516
Open Access
Attitudes and Perceptions of Portuguese Psychiatrists and Psychologists on the Clinical Use of Ketamine
Pedro Mota, Jorge Encantado, Lina Carvalho, et al.
Acta Médica Portuguesa (2025) Vol. 38, Iss. 5, pp. 297-306
Open Access
The safety of supported psilocybin use in Oregon
William Smith, Dominic A. Sisti, Paul S. Appelbaum
Nature Medicine (2024) Vol. 30, Iss. 1, pp. 17-18
Closed Access | Times Cited: 3
Molecular and Medical Aspects of Psychedelics
Adam Wojtas, Krystyna Gołembiowska
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 241-241
Open Access | Times Cited: 8
A taxonomy of regulatory and policy matters relevant to psychedelic-assisted therapy in Australia
Samuel P Hatfield, Nicollette Thornton, Kayla Greenstien, et al.
Australian & New Zealand Journal of Psychiatry (2024) Vol. 58, Iss. 7, pp. 571-590
Open Access | Times Cited: 2
Quality of reporting on psychological interventions in psychedelic treatments: a systematic review
Carolina Seybert, Nina Schimmers, Lucio Silva, et al.
The Lancet Psychiatry (2024)
Closed Access | Times Cited: 2
Classical psychedelics’ action on brain monoaminergic systems
Jasmine Jade Butler, Daria Ricci, Chloé Aman, et al.
The International Journal of Biochemistry & Cell Biology (2024) Vol. 176, pp. 106669-106669
Closed Access | Times Cited: 1
Guruism and Cultic Social Dynamics in Psychedelic Practices and Organisations
Jules Evans, Joel C. Adams
Current topics in behavioral neurosciences (2024)
Closed Access | Times Cited: 1
Dilemmas in psychedelic medicine: From ethics to regulation and equity
Albino J. Oliveira‐Maia, Carolina Seybert
European Neuropsychopharmacology (2024) Vol. 91, pp. 67-68
Closed Access
Page 1

Scroll to top